Ivuxolimab is under investigation in clinical trial NCT02554812 (A Study of Avelumab in Combination With Other Cancer Immunotherapies in Advanced Malignancies (JAVELIN Medley)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.